Barclays Initiates Coverage On Sabra Health Care REIT with Equal-Weight Rating, Announces Price Target of $21
Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. SBRA | 0.00 |
Barclays analyst Richard Hightower initiates coverage on Sabra Health Care REIT (NASDAQ:
SBRA) with a Equal-Weight rating and announces Price Target of $21.
